TGFβ and matrix-regulated epithelial to mesenchymal transition

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 8, 2014, Pages 2621-2634

  Moustakas, Aristidis ^a   Heldin, Paraskevi ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Epithelial mesenchymal transition; Hyaluronan; Proteoglycan; Signal transduction; Transforming growth factor ; Tumor invasiveness

Indexed keywords

CYTOKINE; GLYCOSAMINOGLYCAN; HIGH MOBILITY GROUP A2 PROTEIN; HYALURONAN SYNTHASE 2; HYALURONIC ACID; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PROTEIN P53; SMAD PROTEIN; SMAD2 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SOX4; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VERSICAN;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER STEM CELL; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HUMAN; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR INVASION; TUMOR VASCULARIZATION;

EPITHELIAL-MESENCHYMAL TRANSITION; HYALURONAN; PROTEOGLYCAN; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR Β; TUMOR INVASIVENESS;

ANIMALS; BREAST NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HUMANS; NEOPLASTIC STEM CELLS; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84903515259     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.02.004     Document Type: Review

References (205)

1. M.J. Bissell, A. Rizki, and I.S. Mian Tissue architecture: the ultimate regulator of breast epithelial function Curr. Opin. Cell Biol. 15 2003 753 762
2. E.D. Hay An overview of epithelio-mesenchymal transformation Acta Anat. (Basel) 154 1995 8 20
3. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
4. M. Iwano, D. Plieth, T.M. Danoff, C. Xue, H. Okada, and E.G. Neilson Evidence that fibroblasts derive from epithelium during tissue fibrosis J. Clin. Invest. 110 2002 341 350
5. D. Gao, L.T. Vahdat, S. Wong, J.C. Chang, and V. Mittal Microenvironmental regulation of epithelial-mesenchymal transitions in cancer Cancer Res. 72 2012 4883 4889
6. S. Ansieau, J. Bastid, A. Doreau, A.P. Morel, B.P. Bouchet, C. Thomas, F. Fauvet, I. Puisieux, C. Doglioni, S. Piccinin, R. Maestro, T. Voeltzel, A. Selmi, S. Valsesia-Wittmann, C. Caron de Fromentel, and A. Puisieux Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence Cancer Cell 14 2008 79 89
7. S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, and R.A. Weinberg The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
8. A.P. Morel, M. Lievre, C. Thomas, G. Hinkal, S. Ansieau, and A. Puisieux Generation of breast cancer stem cells through epithelial-mesenchymal transition PLoS One 3 2008 e2888
9. N.A. Bhowmick, and H.L. Moses Tumor-stroma interactions Curr. Opin. Genet. Dev. 15 2005 97 101
10. P. Lu, V.M. Weaver, and Z. Werb The extracellular matrix: a dynamic niche in cancer progression J. Cell Biol. 196 2012 395 406
11. V.M. Weaver, A.H. Fischer, O.W. Peterson, and M.J. Bissell The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay Biochem. Cell Biol. 74 1996 833 851
12. V.M. Weaver, and P. Gilbert Watch thy neighbor: cancer is a communal affair J. Cell Sci. 117 2004 1287 1290
13. A. Kadar, A.M. Tokes, J. Kulka, and L. Robert Extracellular matrix components in breast carcinomas Semin. Cancer Biol. 12 2002 243 257
14. P. Auvinen, R. Tammi, J. Parkkinen, M. Tammi, U. Agren, R. Johansson, P. Hirvikoski, M. Eskelinen, and V.M. Kosma Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival Am. J. Pathol. 156 2000 529 536
15. H.J. Burstein, K. Polyak, J.S. Wong, S.C. Lester, and C.M. Kaelin Ductal carcinoma in situ of the breast N. Engl. J. Med. 350 2004 1430 1441
16. J. Muschler, and C.H. Streuli Cell-matrix interactions in mammary gland development and breast cancer Cold Spring Harb. Perspect. Biol. 2 2010 a003202
17. B. Tiede, and Y. Kang From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer Cell Res. 21 2011 245 257
18. M. de la Torre, A.F. Wells, J. Bergh, and A. Lindgren Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma Hum. Pathol. 24 1993 1294 1297
19. N. Itano, and K. Kimata Altered hyaluronan biosynthesis in cancer progression Semin. Cancer Biol. 18 2008 268 274
20. H. Koyama, T. Hibi, Z. Isogai, M. Yoneda, M. Fujimori, J. Amano, M. Kawakubo, R. Kannagi, K. Kimata, S. Taniguchi, and N. Itano Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M Am. J. Pathol. 170 2007 1086 1099
21. P.P. Provenzano, D.R. Inman, K.W. Eliceiri, J.G. Knittel, L. Yan, C.T. Rueden, J.G. White, and P.J. Keely Collagen density promotes mammary tumor initiation and progression BMC Med. 6 2008 11
22. S. Suwiwat, C. Ricciardelli, R. Tammi, M. Tammi, P. Auvinen, V.M. Kosma, R.G. LeBaron, W.A. Raymond, W.D. Tilley, and D.J. Horsfall Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer Clin. Cancer Res. 10 2004 2491 2498
23. J. Fuxe, and M.C. Karlsson TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation Semin. Cancer Biol. 22 2012 455 461
24. M.A. Nieto The ins and outs of the epithelial to mesenchymal transition in health and disease Annu. Rev. Cell Dev. Biol. 27 2011 347 376
25. E. Batlle, E. Sancho, C. Franci, D. Dominguez, M. Monfar, J. Baulida, and A. Garcia De Herreros The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells Nat. Cell Biol. 2 2000 84 89
26. A. Cano, M.A. Perez-Moreno, I. Rodrigo, A. Locascio, M.J. Blanco, M.G. del Barrio, F. Portillo, and M.A. Nieto The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression Nat. Cell Biol. 2 2000 76 83
27. K.M. Hajra, D.Y. Chen, and E.R. Fearon The SLUG zinc-finger protein represses E-cadherin in breast cancer Cancer Res. 62 2002 1613 1618
28. V. Bolos, H. Peinado, M.A. Perez-Moreno, M.F. Fraga, M. Esteller, and A. Cano The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors J. Cell Sci. 116 2003 499 511
29. A. Eger, K. Aigner, S. Sonderegger, B. Dampier, S. Oehler, M. Schreiber, G. Berx, A. Cano, H. Beug, and R. Foisner is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells Oncogene 24 2005 2375 2385
30. J. Comijn, G. Berx, P. Vermassen, K. Verschueren, L. van Grunsven, E. Bruyneel, M. Mareel, D. Huylebroeck, and F. van Roy The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion Mol. Cell 7 2001 1267 1278
31. M.A. Perez-Moreno, A. Locascio, I. Rodrigo, G. Dhondt, F. Portillo, M.A. Nieto, and A. Cano A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions J. Biol. Chem. 276 2001 27424 27431
32. J. Yang, S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, and R.A. Weinberg Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 117 2004 927 939
33. E.-J. Tan, S. Thuault, L. Caja, T. Carletti, C.-H. Heldin, and A. Moustakas Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition J. Biol. Chem. 287 2012 7134 7145
34. S. Thuault, E.-J. Tan, H. Peinado, A. Cano, C.-H. Heldin, and A. Moustakas HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition J. Biol. Chem. 283 2008 33437 33446
35. S. Thuault, U. Valcourt, M. Petersen, G. Manfioletti, C.H. Heldin, and A. Moustakas Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition J. Cell Biol. 174 2006 175 183
36. B. De Craene, and G. Berx Regulatory networks defining EMT during cancer initiation and progression Nat. Rev. Cancer 13 2013 97 110
37. Y. Katsuno, S. Lamouille, and R. Derynck TGF-β signaling and epithelial-mesenchymal transition in cancer progression Curr. Opin. Oncol. 25 2013 76 84
38. A. Moustakas, and C.-H. Heldin Induction of epithelial-mesenchymal transition by transforming growth factor β Semin. Cancer Biol. 22 2012 446 454
39. M. Pickup, S. Novitskiy, and H.L. Moses The roles of TGFβ in the tumour microenvironment Nat. Rev. Cancer 13 2013 788 799
40. A. Gal, T. Sjöblom, L. Fedorova, S. Imreh, H. Beug, and A. Moustakas Sustained TGF β exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis Oncogene 27 2008 1218 1230
41. P.J. Miettinen, R. Ebner, A.R. Lopez, and R. Derynck TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors J. Cell Biol. 127 1994 2021 2036
42. U. Valcourt, M. Kowanetz, H. Niimi, C.-H. Heldin, and A. Moustakas TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition Mol. Biol. Cell 16 2005 1987 2002
43. E. Janda, K. Lehmann, I. Killisch, M. Jechlinger, M. Herzig, J. Downward, H. Beug, and S. Grunert Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways J. Cell Biol. 156 2002 299 313
44. L. Waldmeier, N. Meyer-Schaller, M. Diepenbruck, and G. Christofori Py2T murine breast cancer cells, a versatile model of TGFβ-induced EMT in vitro and in vivo PLoS One 7 2012 e48651
45. A. Sakaue-Sawano, H. Kurokawa, T. Morimura, A. Hanyu, H. Hama, H. Osawa, S. Kashiwagi, K. Fukami, T. Miyata, H. Miyoshi, T. Imamura, M. Ogawa, H. Masai, and A. Miyawaki Visualizing spatiotemporal dynamics of multicellular cell-cycle progression Cell 132 2008 487 498
46. J. Massagué TGFβ signalling in context Nat. Rev. Mol. Cell Biol. 13 2012 616 630
47. B. Ozdamar, R. Bose, M. Barrios-Rodiles, H.R. Wang, Y. Zhang, and J.L. Wrana Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity Science 307 2005 1603 1609
48. A. Gunaratne, B.L. Thai, and G.M. Di Guglielmo Atypical protein kinase C phosphorylates Par6 and facilitates transforming growth factor β-induced epithelial-to-mesenchymal transition Mol. Cell. Biol. 33 2013 874 886
49. Y. Mu, R. Sundar, N. Thakur, M. Ekman, S.K. Gudey, M. Yakymovych, A. Hermansson, H. Dimitriou, M.T. Bengoechea-Alonso, J. Ericsson, C.-H. Heldin, and M. Landström TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer Nat. Commun. 2 2011 330
50. A.V. Bakin, A.K. Tomlinson, N.A. Bhowmick, H.L. Moses, and C.L. Arteaga Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration J. Biol. Chem. 275 2000 36803 36810
51. A.V. Bakin, C. Rinehart, A.K. Tomlinson, and C.L. Arteaga p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration J. Cell Sci. 115 2002 3193 3206
52. A.J. Galliher, and W.P. Schiemann Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion Cancer Res. 67 2007 3752 3758
53. N.A. Bhowmick, M. Ghiassi, A. Bakin, M. Aakre, C.A. Lundquist, M.E. Engel, C.L. Arteaga, and H.L. Moses Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism Mol. Biol. Cell 12 2001 27 36
54. C. Cicchini, I. Laudadio, F. Citarella, M. Corazzari, C. Steindler, A. Conigliaro, A. Fantoni, L. Amicone, and M. Tripodi TGFβ-induced EMT requires focal adhesion kinase (FAK) signaling Exp. Cell Res. 314 2008 143 152
55. M.K. Wendt, M. Tian, and W.P. Schiemann Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression Cell Tissue Res. 347 2012 85 101
56. S. Lamouille, E. Connolly, J.W. Smyth, R.J. Akhurst, and R. Derynck TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion J. Cell Sci. 125 2012 1259 1273
57. I. Serrano, P.C. McDonald, F.E. Lock, and S. Dedhar Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT) Oncogene 32 2013 50 60
58. I. Mikaelian, M. Malek, R. Gadet, J. Viallet, A. Garcia, A. Girard-Gagnepain, C. Hesling, G. Gillet, P. Gonzalo, R. Rimokh, and M. Billaud Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism Cancer Res. 73 2013 6621 6631
59. S. Lamouille, and R. Derynck Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway J. Cell Biol. 178 2007 437 451
60. Q. Liang, L. Li, J. Zhang, Y. Lei, L. Wang, D.X. Liu, J. Feng, P. Hou, R. Yao, Y. Zhang, B. Huang, and J. Lu CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression Sci. Rep. 3 2013 2932
61. G. Xue, D.F. Restuccia, Q. Lan, D. Hynx, S. Dirnhofer, D. Hess, C. Ruegg, and B.A. Hemmings Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes Cancer Discov. 2 2012 248 259
62. A. Morishita, M.R. Zaidi, A. Mitoro, D. Sankarasharma, M. Szabolcs, Y. Okada, J. D'Armiento, and K. Chada HMGA2 is a driver of tumor metastasis Cancer Res. 73 2013 4289 4299
63. R. Reeves, D.D. Edberg, and Y. Li Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells Mol. Cell. Biol. 21 2001 575 594
64. S. Pegoraro, G. Ros, S. Piazza, R. Sommaggio, Y. Ciani, A. Rosato, R. Sgarra, G. Del Sal, and G. Manfioletti HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness Oncotarget 4 2013 1293 1308
65. O.G. McDonald, H. Wu, W. Timp, A. Doi, and A.P. Feinberg Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition Nat. Struct. Mol. Biol. 18 2011 867 874
66. C. Dong, Y. Wu, J. Yao, Y. Wang, Y. Yu, P.G. Rychahou, B.M. Evers, and B.P. Zhou G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer J. Clin. Invest. 122 2012 1469 1486
67. C. Dong, T. Yuan, Y. Wu, Y. Wang, T.W. Fan, S. Miriyala, Y. Lin, J. Yao, J. Shi, T. Kang, P. Lorkiewicz, D. St Clair, M.C. Hung, B.M. Evers, and B.P. Zhou Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer Cancer Cell 23 2013 316 331
68. G.G. Malouf, J.H. Taube, Y. Lu, T. Roysarkar, S. Panjarian, M.R. Estecio, J. Jelinek, J. Yamazaki, N.J. Raynal, H. Long, T. Tahara, A. Tinnirello, P. Ramachandran, X.Y. Zhang, S. Liang, S.A. Mani, and J.P. Issa Architecture of epigenetic reprogramming following Twist1 mediated epithelial-mesenchymal transition Genome Biol. 14 2013 R144
69. S. Ramadoss, X. Chen, and C.Y. Wang Histone demethylase KDM6B promotes epithelial-mesenchymal transition J. Biol. Chem. 287 2012 44508 44517
70. D.P. Munoz, E.L. Lee, S. Takayama, J.P. Coppe, S.J. Heo, D. Boffelli, J.M. Di Noia, and D.I. Martin Activation-induced cytidine deaminase (AID) is necessary for the epithelial-mesenchymal transition in mammary epithelial cells Proc. Natl. Acad. Sci. U. S. A. 110 2013 E2977 E2986
71. S. Huang, M. Holzel, T. Knijnenburg, A. Schlicker, P. Roepman, U. McDermott, M. Garnett, W. Grernrum, C. Sun, A. Prahallad, F.H. Groenendijk, L. Mittempergher, W. Nijkamp, J. Neefjes, R. Salazar, P. Ten Dijke, H. Uramoto, F. Tanaka, R.L. Beijersbergen, L.F. Wessels, and R. Bernards MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling Cell 151 2012 937 950
72. P. Simic, E.O. Williams, E.L. Bell, J.J. Gong, M. Bonkowski, and L. Guarente SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis Cell Rep. 3 2013 1175 1186
73. N. Chen, S. Balasenthil, J. Reuther, A. Frayna, Y. Wang, D.S. Chandler, L.V. Abruzzo, A. Rashid, J. Rodriguez, G. Lozano, Y. Cao, E. Lokken, J. Chen, M.L. Frazier, A.A. Sahin, I.I. Wistuba, S. Sen, S.T. Lott, and A.M. Killary DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition Cancer Discov. 3 2013 1172 1189
74. J.A. Vendrell, A. Thollet, N.T. Nguyen, S.E. Ghayad, S. Vinot, I. Bieche, E. Grisard, V. Josserand, J.L. Coll, P. Roux, L. Corbo, I. Treilleux, R. Rimokh, and P.A. Cohen ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion Cancer Res. 72 2012 3593 3606
75. J. Zhang, Q. Liang, Y. Lei, M. Yao, L. Li, X. Gao, J. Feng, Y. Zhang, H. Gao, D.X. Liu, J. Lu, and B. Huang SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression Cancer Res. 72 2012 4597 4608
76. S.J. Vervoort, A.R. Lourenco, R. van Boxtel, and P.J. Coffer SOX4 mediates TGF-β-induced expression of mesenchymal markers during mammary cell epithelial to mesenchymal transition PLoS One 8 2013 e53238
77. N. Tiwari, V.K. Tiwari, L. Waldmeier, P.J. Balwierz, P. Arnold, M. Pachkov, N. Meyer-Schaller, D. Schubeler, E. van Nimwegen, and G. Christofori Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming Cancer Cell 23 2013 768 783
78. A. Sundqvist, P. ten Dijke, and H. van Dam Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity Breast Cancer Res. 14 2012 204
79. A. Sundqvist, A. Zieba, E. Vasilaki, C. Herrera Hidalgo, O. Soderberg, D. Koinuma, K. Miyazono, C.-H. Heldin, U. Landegren, P. ten Dijke, and H. van Dam Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion Oncogene 32 2013 3606 3615
80. S. Sengupta, S. Jana, S. Biswas, P.K. Mandal, and A. Bhattacharyya Cooperative involvement of NFAT and SnoN mediates transforming growth factor-β (TGF-β) induced EMT in metastatic breast cancer (MDA-MB 231) cells Clin. Exp. Metastasis 30 2013 1019 1031
81. M. Romagnoli, K. Belguise, Z. Yu, X. Wang, E. Landesman-Bollag, D.C. Seldin, D. Chalbos, S. Barille-Nion, P. Jezequel, M.L. Seldin, and G.E. Sonenshein Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5 Cancer Res. 72 2012 6268 6278
82. M. Kowanetz, U. Valcourt, R. Bergstrom, C.H. Heldin, and A. Moustakas Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor β and bone morphogenetic protein Mol. Cell. Biol. 24 2004 4241 4254
83. M. Kondo, E. Cubillo, K. Tobiume, T. Shirakihara, N. Fukuda, H. Suzuki, K. Shimizu, K. Takehara, A. Cano, M. Saitoh, and K. Miyazono A role for Id in the regulation of TGF-β-induced epithelial-mesenchymal transdifferentiation Cell Death Differ. 11 2004 1092 1101
84. M. Gervasi, A. Bianchi-Smiraglia, M. Cummings, Q. Zheng, D. Wang, S. Liu, and A.V. Bakin JunB contributes to Id2 repression and the epithelial- mesenchymal transition in response to transforming growth factor-β J. Cell Biol. 196 2012 589 603
85. M.B. Ruzinova, and R. Benezra Id proteins in development, cell cycle and cancer Trends Cell Biol. 13 2003 410 418
86. M. Stankic, S. Pavlovic, Y. Chin, E. Brogi, D. Padua, L. Norton, J. Massagué, and R. Benezra TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition Cell Rep. 5 2013 1228 1242
87. C. Chang, X. Yang, B. Pursell, and A.M. Mercurio Id2 complexes with the SNAG domain of Snai1 inhibiting Snai1-mediated repression of integrin β4 Mol. Cell. Biol. 33 2013 3795 3804
88. 3 expression Cell Oncol. (Dordr) 35 2012 19 28
89. J.T. Buijs, N.V. Henriquez, P.G. van Overveld, G. van der Horst, P. ten Dijke, and G. van der Pluijm TGF-β and BMP7 interactions in tumour progression and bone metastasis Clin. Exp. Metastasis 24 2007 609 617
90. C.J. Chang, C.H. Chao, W. Xia, J.Y. Yang, Y. Xiong, C.W. Li, W.H. Yu, S.K. Rehman, J.L. Hsu, H.H. Lee, M. Liu, C.T. Chen, D. Yu, and M.C. Hung p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs Nat. Cell Biol. 13 2011 317 323
91. N.H. Kim, H.S. Kim, X.Y. Li, I. Lee, H.S. Choi, S.E. Kang, S.Y. Cha, J.K. Ryu, D. Yoon, E.R. Fearon, R.G. Rowe, S. Lee, C.A. Maher, S.J. Weiss, and J.I. Yook A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition J. Cell Biol. 195 2011 417 433
92. H. Siemens, R. Jackstadt, S. Hunten, M. Kaller, A. Menssen, U. Gotz, and H. Hermeking miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions Cell Cycle 10 2011 4256 4271
93. S. Termén, E.J. Tan, C.-H. Heldin, and A. Moustakas p53 regulates epithelial-mesenchymal transition induced by transforming growth factor β J. Cell. Physiol. 228 2013 801 813
94. Y. Wu, Y. Fu, L. Zheng, G. Lin, J. Ma, J. Lou, H. Zhu, Q. He, and B. Yang Nutlin-3 inhibits epithelial-mesenchymal transition by interfering with canonical transforming growth factor-β1-Smad-Snail/Slug axis Cancer Lett. 342 2014 82 91
95. J.I. Herschkowitz, W. Zhao, M. Zhang, J. Usary, G. Murrow, D. Edwards, J. Knezevic, S.B. Greene, D. Darr, M.A. Troester, S.G. Hilsenbeck, D. Medina, C.M. Perou, and J.M. Rosen Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells Proc. Natl. Acad. Sci. U. S. A. 109 2012 2778 2783
96. J.A. Wright, J.K. Richer, and G.J. Goodall microRNAs and EMT in mammary cells and breast cancer J. Mammary Gland Biol. Neoplasia 15 2010 213 223
97. S. Brabletz, and T. Brabletz The ZEB/miR-200 feedback loop - a motor of cellular plasticity in development and cancer? EMBO Rep. 11 2010 670 677
98. Y. Wang, M. Wen, Y. Kwon, Y. Xu, Y. Liu, P. Zhang, X. He, Q. Wang, Y. Huang, K.Y. Jen, M.A. Labarge, L. You, S.C. Kogan, J.W. Gray, J.H. Mao, and G. Wei CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression Cancer Res. 74 2014 520 531
99. P.A. Gregory, C.P. Bracken, E. Smith, A.G. Bert, J.A. Wright, S. Roslan, M. Morris, L. Wyatt, G. Farshid, Y.Y. Lim, G.J. Lindeman, M.F. Shannon, P.A. Drew, Y. Khew-Goodall, and G.J. Goodall An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition Mol. Biol. Cell 22 2011 1686 1698
100. H.J. Hugo, L. Pereira, R. Suryadinata, Y. Drabsch, T.J. Gonda, N.P. Gunasinghe, C. Pinto, E.T. Soo, B. van Denderen, P. Hill, R.G. Ramsay, B. Sarcevic, D.F. Newgreen, and E.W. Thompson Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells Breast Cancer Res. 15 2013 R113
101. A.P. Smith, A. Verrecchia, G. Faga, M. Doni, D. Perna, F. Martinato, E. Guccione, and B. Amati A positive role for Myc in TGFβ-induced Snail transcription and epithelial-to-mesenchymal transition Oncogene 28 2009 422 430
102. X. Ding, S.I. Park, L.K. McCauley, and C.Y. Wang Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis J. Biol. Chem. 288 2013 10241 10253
103. J. Johansson, T. Berg, E. Kurzejamska, M.F. Pang, V. Tabor, M. Jansson, P. Roswall, K. Pietras, M. Sund, P. Religa, and J. Fuxe MiR-155-mediated loss of C/EBPb shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer Oncogene 32 2013 5614 5624
104. S.J. Song, K. Ito, U. Ala, L. Kats, K. Webster, S.M. Sun, M. Jongen-Lavrencic, K. Manova-Todorova, J. Teruya-Feldstein, D.E. Avigan, R. Delwel, and P.P. Pandolfi The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation Cell Stem Cell 13 2013 87 101
105. C.P. Alves, A.S. Fonseca, B.R. Muys, E.L.B.R. de Barros, M.C. Burger, J.E. de Souza, V. Valente, M.A. Zago, and W.A. Silva Jr. The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cells lines Stem Cells 31 2013 2827 2832
106. P. Hu, J. Yang, Y. Hou, H. Zhang, Z. Zeng, L. Zhao, T. Yu, X. Tang, G. Tu, X. Cui, and M. Liu LncRNA expression signatures of twist-induced epithelial-to-mesenchymal transition in MCF10A cells Cell. Signal. 26 2014 83 93
107. C.C. Warzecha, P. Jiang, K. Amirikian, K.A. Dittmar, H. Lu, S. Shen, W. Guo, Y. Xing, and R.P. Carstens An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition EMBO J. 29 2010 3286 3300
108. K. Horiguchi, K. Sakamoto, D. Koinuma, K. Semba, A. Inoue, S. Inoue, H. Fujii, A. Yamaguchi, K. Miyazawa, K. Miyazono, and M. Saitoh TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP Oncogene 31 2012 3190 3201
109. I.M. Shapiro, A.W. Cheng, N.C. Flytzanis, M. Balsamo, J.S. Condeelis, M.H. Oktay, C.B. Burge, and F.B. Gertler An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype PLoS Genet. 7 2011 e1002218
110. C. Braeutigam, L. Rago, A. Rolke, L. Waldmeier, G. Christofori, and J. Winter The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion Oncogene 33 2014 1082 1092
111. T. Waerner, M. Alacakaptan, I. Tamir, R. Oberauer, A. Gal, T. Brabletz, M. Schreiber, M. Jechlinger, and H. Beug ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells Cancer Cell 10 2006 227 239
112. A. Chaudhury, G.S. Hussey, P.S. Ray, G. Jin, P.L. Fox, and P.H. Howe TGF-b-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI Nat. Cell Biol. 12 2010 286 293
113. G.S. Hussey, A. Chaudhury, A.E. Dawson, D.J. Lindner, C.R. Knudsen, M.C. Wilce, W.C. Merrick, and P.H. Howe Identification of an mRNP complex regulating tumorigenesis at the translational elongation step Mol. Cell 41 2011 419 431
114. G.S. Hussey, L.A. Link, A.S. Brown, B.V. Howley, A. Chaudhury, and P.H. Howe Establishment of a TGFb-induced post-transcriptional EMT gene signature PLoS One 7 2012 e52624
115. N. Afratis, C. Gialeli, D. Nikitovic, T. Tsegenidis, E. Karousou, A.D. Theocharis, M.S. Pavao, G.N. Tzanakakis, and N.K. Karamanos Glycosaminoglycans: key players in cancer cell biology and treatment FEBS J. 279 2012 1177 1197
116. M. Dong, T. How, K.C. Kirkbride, K.J. Gordon, J.D. Lee, N. Hempel, P. Kelly, B.J. Moeller, J.R. Marks, and G.C. Blobe The type III TGF-β receptor suppresses breast cancer progression J. Clin. Invest. 117 2007 206 217
117. B.A. Hanks, A. Holtzhausen, K.S. Evans, R. Jamieson, P. Gimpel, O.M. Campbell, M. Hector-Greene, L. Sun, A. Tewari, A. George, M. Starr, A. Nixon, C. Augustine, G. Beasley, D.S. Tyler, T. Osada, M.A. Morse, L. Ling, H.K. Lyerly, and G.C. Blobe Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment J. Clin. Invest. 123 2013 3925 3940
118. K. Mythreye, and G.C. Blobe The type III TGF-β receptor regulates epithelial and cancer cell migration through β-arrestin2-mediated activation of Cdc42 Proc. Natl. Acad. Sci. U. S. A. 106 2009 8221 8226
119. J. Park, and J.E. Schwarzbauer Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition Oncogene 2013 10.1038/onc.2013.118 (Epub ahead of print)
120. Q. Xu, T. Isaji, Y. Lu, W. Gu, M. Kondo, T. Fukuda, Y. Du, and J. Gu Roles of N-acetylglucosaminyltransferase III in epithelial-to-mesenchymal transition induced by transforming growth factor β1 (TGF-β1) in epithelial cell lines J. Biol. Chem. 287 2012 16563 16574
121. Y.C. Lin, Y.C. Lee, L.H. Li, C.J. Cheng, and R.B. Yang Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition J. Cell Sci. 127 2014 85 100
122. M. Allegra, A. Zaragkoulias, E. Vorgia, M. Ioannou, G. Litos, H. Beug, and G. Mavrothalassitis Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells Mol. Biol. Cell 23 2012 3873 3881
123. R. Chakrabarti, J. Hwang, M. Andres Blanco, Y. Wei, M. Lukacisin, R.A. Romano, K. Smalley, S. Liu, Q. Yang, T. Ibrahim, L. Mercatali, D. Amadori, B.G. Haffty, S. Sinha, and Y. Kang Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2 Nat. Cell Biol. 14 2012 1212 1222
124. M.A. Eckert, T.M. Lwin, A.T. Chang, J. Kim, E. Danis, L. Ohno-Machado, and J. Yang Twist1-induced invadopodia formation promotes tumor metastasis Cancer Cell 19 2011 372 386
125. T. Shibue, M.W. Brooks, M.F. Inan, F. Reinhardt, and R.A. Weinberg The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions Cancer Discov. 2 2012 706 721
126. J. Pignatelli, D.A. Tumbarello, R.P. Schmidt, and C.E. Turner Hic-5 promotes invadopodia formation and invasion during TGF-β-induced epithelial-mesenchymal transition J. Cell Biol. 197 2012 421 437
127. E. Ngan, J.J. Northey, C.M. Brown, J. Ursini-Siegel, and P.M. Siegel A complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells J. Cell Sci. 126 2013 1981 1991
128. K. Zhang, C.A. Corsa, S.M. Ponik, J.L. Prior, D. Piwnica-Worms, K.W. Eliceiri, P.J. Keely, and G.D. Longmore The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis Nat. Cell Biol. 15 2013 677 687
129. C.D. Morrison, J.G. Parvani, and W.P. Schiemann The relevance of the TGF-β paradox to EMT-MET programs Cancer Lett. 341 2013 30 40
130. J.J. Doyle, E.E. Gerber, and H.C. Dietz Matrix-dependent perturbation of TGFβ signaling and disease FEBS Lett. 586 2012 2003 2015
131. M.A. Travis, and D. Sheppard TGF-β activation and function in immunity Annu. Rev. Immunol. 2013 (Epub ahead of print) PMID: 24313777
132. T. Shirakihara, T. Kawasaki, A. Fukagawa, K. Semba, R. Sakai, K. Miyazono, K. Miyazawa, and M. Saitoh Identification of integrin α3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes Cancer Sci. 104 2013 1189 1197
133. J.G. Parvani, A.J. Galliher-Beckley, B.J. Schiemann, and W.P. Schiemann Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β Mol. Biol. Cell 24 2013 3449 3459
134. M.K. Wendt, B.J. Schiemann, J.G. Parvani, Y.H. Lee, Y. Kang, and W.P. Schiemann TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer Oncogene 32 2013 2005 2015
135. T.C. Laurent, and J.R.E. Fraser Hyaluronan FASEB J. 6 1992 2397 2404
136. B.P. Toole Hyaluronan: from extracellular glue to pericellular cue Nat. Rev. Cancer 4 2004 528 539
137. M. Wernicke, L.C. Pineiro, D. Caramutti, V.G. Dorn, M.M. Raffo, H.G. Guixa, M. Telenta, and A.A. Morandi Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan Mod. Pathol. 16 2003 99 107
138. P. Vignal, M.R. Meslet, J.M. Romeo, and F. Feuilhade Sonographic morphology of infiltrating breast carcinoma: relationship with the shape of the hyaluronan extracellular matrix J. Ultrasound Med. 21 2002 532 538
139. B. Delpech, B. Chevallier, N. Reinhardt, J.P. Julien, C. Duval, C. Maingonnat, P. Bastit, and B. Asselain Serum hyaluronan (hyaluronic acid) in breast cancer patients Int. J. Cancer 46 1990 388 390
140. G.K. Malhotra, X. Zhao, H. Band, and V. Band Histological, molecular and functional subtypes of breast cancers Cancer Biol. Ther. 10 2010 955 960
141. R. Sandhu, J.S. Parker, W.D. Jones, C.A. Livasy, and W.B. Coleman Microarray-based gene expression profiling for molecular classification of breast cancer and identification of new targets for therapy Lab. Med. 41 2010 364 372
142. J.S. Parker, M. Mullins, M.C. Cheang, S. Leung, D. Voduc, T. Vickery, S. Davies, C. Fauron, X. He, Z. Hu, J.F. Quackenbush, I.J. Stijleman, J. Palazzo, J.S. Marron, A.B. Nobel, E. Mardis, T.O. Nielsen, M.J. Ellis, C.M. Perou, and P.S. Bernard Supervised risk predictor of breast cancer based on intrinsic subtypes J. Clin. Oncol. 27 2009 1160 1167
143. A. Bergamaschi, E. Tagliabue, T. Sorlie, B. Naume, T. Triulzi, R. Orlandi, H.G. Russnes, J.M. Nesland, R. Tammi, P. Auvinen, V.M. Kosma, S. Menard, and A.L. Borresen-Dale Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome J. Pathol. 214 2008 357 367
144. R. Stern Hyaluronan metabolism: a major paradox in cancer biology Pathol. Biol. (Paris) 53 2005 372 382
145. P. Heldin, K. Basu, B. Olofsson, H. Porsch, I. Kozlova, and K. Kahata Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer J. Biochem. 154 2013 395 408
146. J.E. Fata, Z. Werb, and M.J. Bissell Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes Breast Cancer Res. 6 2004 1 11
147. D.H. Ausprunk Distribution of hyaluronic acid and sulfated glycosaminoglycans during blood-vessel development in the chick chorioallantoic membrane Am. J. Anat. 177 1986 313 331
148. H. Ponta, L. Sherman, and P.A. Herrlich CD44: from adhesion molecules to signalling regulators Nat. Rev. Mol. Cell Biol. 4 2003 33 45
149. Y. Takahashi, L. Li, M. Kamiryo, T. Asteriou, A. Moustakas, H. Yamashita, and P. Heldin Hyaluronan fragments induce endothelial cell differentiation in a CD44- and CXCL1/GRO1-dependent manner J. Biol. Chem. 280 2005 24195 24204
150. G. Cao, R.C. Savani, M. Fehrenbach, C. Lyons, L. Zhang, G. Coukos, and H.M. Delisser Involvement of endothelial CD44 during in vivo angiogenesis Am. J. Pathol. 169 2006 325 336
151. L. Li, C.H. Heldin, and P. Heldin Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44 J. Biol. Chem. 281 2006 26512 26519
152. V. Orian-Rousseau, and H. Ponta Adhesion proteins meet receptors: a common theme? Adv. Cancer Res. 101 2008 63 92
153. S.R. Hamilton, S.F. Fard, F.F. Paiwand, C. Tolg, M. Veiseh, C. Wang, J.B. McCarthy, M.J. Bissell, J. Koropatnick, and E.A. Turley The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells J. Biol. Chem. 282 2007 16667 16680
154. C.P. El-Haibi, G.W. Bell, J. Zhang, A.Y. Collmann, D. Wood, C.M. Scherber, E. Csizmadia, O. Mariani, C. Zhu, A. Campagne, M. Toner, S.N. Bhatia, D. Irimia, A. Vincent-Salomon, and A.E. Karnoub Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy Proc. Natl. Acad. Sci. U. S. A. 109 2012 17460 17465
155. N. Itano, T. Sawai, O. Miyaishi, and K. Kimata Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells Cancer Res. 59 1999 2499 2504
156. N. Itano, T. Sawai, M. Yoshida, P. Lenas, Y. Yamada, M. Imagawa, T. Shinomura, M. Hamaguchi, and Y. Yoshida Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties J. Biol. Chem. 274 1999 25085 25092
157. J. Brinck, and P. Heldin Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44 Exp. Cell Res. 252 1999 342 351
158. A. Jacobson, J. Brinck, M.J. Briskin, A.P. Spicer, and P. Heldin Expression of human hyaluronan synthases in response to external stimuli Biochem. J. 348 Pt 1 2000 29 35
159. A.D. Recklies, C. White, L. Melching, and P.J. Roughley Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells Biochem. J. 354 2001 17 24
160. M. Suzuki, T. Asplund, H. Yamashita, C.-H. Heldin, and P. Heldin Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-β1 involves activation of protein kinase C Biochem. J. 307 1995 817 821
161. B.J. Goentzel, P.H. Weigel, and R.A. Steinberg Recombinant human hyaluronan synthase 3 is phosphorylated in mammalian cells Biochem. J. 396 2006 347 354
162. D. Vigetti, M. Clerici, S. Deleonibus, E. Karousou, M. Viola, P. Moretto, P. Heldin, V.C. Hascall, G. De Luca, and A. Passi Hyaluronan synthesis is inhibited by adenosine monophosphate-activated protein kinase through the regulation of HAS2 activity in human aortic smooth muscle cells J. Biol. Chem. 286 2011 7917 7924
163. E. Karousou, M. Kamiryo, S.S. Skandalis, A. Ruusala, T. Asteriou, A. Passi, H. Yamashita, U. Hellman, C.-H. Heldin, and P. Heldin The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination J. Biol. Chem. 285 2010 23647 23654
164. R.H. Tammi, A.G. Passi, K. Rilla, E. Karousou, D. Vigetti, K. Makkonen, and M. Tammi Transcriptional and post-translational regulation of hyaluronan synthesis FEBS J. 278 2011 1419 1428
165. N. Itano, T. Sawai, F. Atsumi, O. Miyaishi, S. Taniguchi, R. Kannagi, M. Hamaguchi, and K. Kimata Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation J. Biol. Chem. 279 2004 18679 18687
166. A. Zoltan-Jones, L. Huang, S. Ghatak, and B.P. Toole Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells J. Biol. Chem. 278 2003 45801 45810
167. H. Porsch, B. Bernert, M. Mehic, A.D. Theocharis, C.-H. Heldin, and P. Heldin Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2 Oncogene 32 2013 4355 4365
168. J. Bakkers, C. Kramer, J. Pothof, N.E.M. Quaedvlieg, H.P. Spaink, and M. Hammerschmidt Has2 is required upstream of Rac1 to govern dorsal migration of lateral cells during zebrafish gastrulation Development 131 2004 525 537
169. I. Kozlova, A. Ruusala, O. Voytyuk, S.S. Skandalis, and P. Heldin IQGAP1 regulates hyaluronan-mediated fibroblast motility and proliferation Cell. Signal. 24 2012 1856 1862
170. T.D. Camenisch, J.A. Schroeder, J. Bradley, S.E. Klewer, and J.A. McDonald Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors Nat. Med. 8 2002 850 855
171. A.K. Lagendijk, M.J. Goumans, S.B. Burkhard, and J. Bakkers MicroRNA-23 restricts cardiac valve formation by inhibiting Has2 and extracellular hyaluronic acid production Circ. Res. 109 2011 649 657
172. Y. Li, and P. Heldin Hyaluronan production increases the malignant properties of mesothelioma cells Br. J. Cancer 85 2001 600 607
173. A. Jacobson, M. Rahmanian, K. Rubin, and P. Heldin Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors Int. J. Cancer 102 2002 212 219
174. L. Li, T. Asteriou, B. Bernert, C.-H. Heldin, and P. Heldin Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB Biochem. J. 404 2007 327 336
175. L. Udabage, G.R. Brownlee, M. Waltham, T. Blick, E.C. Walker, P. Heldin, S.K. Nilsson, E.W. Thompson, and T.J. Brown Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer Cancer Res. 65 2005 6139 6150
176. D.C. West, I.N. Hampson, F. Arnold, and S. Kumar Angiogenesis induced by degradation products of hyaluronic acid Science 228 1985 1324 1326
177. P. Rooney, and S. Kumar Inverse relationship between hyaluronan and collagens in development and angiogenesis Differentiation 54 1993 1 9
178. Y. Li, L. Li, T.J. Brown, and P. Heldin Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells Int. J. Cancer 120 2007 2557 2567
179. A.B. Tuck, B.E. Elliott, C. Hota, E. Tremblay, and A.F. Chambers Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met) J. Cell. Biochem. 78 2000 465 475
180. B. Bernert, H. Porsch, and P. Heldin Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1) J. Biol. Chem. 286 2011 42349 42359
181. D.M. Kuang, Y. Wu, N. Chen, J. Cheng, S.M. Zhuang, and L. Zheng Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes Blood 110 2007 587 595
182. D.N. Haylock, and S.K. Nilsson The role of hyaluronic acid in hemopoietic stem cell biology Regen. Med. 1 2006 437 445
183. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U. S. A. 100 2003 3983 3988
184. W.L. Tam, and R.A. Weinberg The epigenetics of epithelial-mesenchymal plasticity in cancer Nat. Med. 19 2013 1438 1449
185. S. Yamanaka, and H.M. Blau Nuclear reprogramming to a pluripotent state by three approaches Nature 465 2010 704 712
186. X. Liu, H. Sun, J. Qi, L. Wang, S. He, J. Liu, C. Feng, C. Chen, W. Li, Y. Guo, D. Qin, G. Pan, J. Chen, D. Pei, and H. Zheng Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming Nat. Cell Biol. 15 2013 829 838
187. P. Samavarchi-Tehrani, A. Golipour, L. David, H.K. Sung, T.A. Beyer, A. Datti, K. Woltjen, A. Nagy, and J.L. Wrana Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming Cell Stem Cell 7 2010 64 77
188. C. Scheel, E.N. Eaton, S.H. Li, C.L. Chaffer, F. Reinhardt, K.J. Kah, G. Bell, W. Guo, J. Rubin, A.L. Richardson, and R.A. Weinberg Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast Cell 145 2011 926 940
189. B.G. Hollier, A.A. Tinnirello, S.J. Werden, K.W. Evans, J.H. Taube, T.R. Sarkar, N. Sphyris, M. Shariati, S.V. Kumar, V.L. Battula, J.I. Herschkowitz, R. Guerra, J.T. Chang, N. Miura, J.M. Rosen, and S.A. Mani FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer Cancer Res. 73 2013 1981 1992
190. M. Cordenonsi, F. Zanconato, L. Azzolin, M. Forcato, A. Rosato, C. Frasson, M. Inui, M. Montagner, A.R. Parenti, A. Poletti, M.G. Daidone, S. Dupont, G. Basso, S. Bicciato, and S. Piccolo The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells Cell 147 2011 759 772
191. B. Cieply, J. Farris, J. Denvir, H.L. Ford, and S.M. Frisch Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2 Cancer Res. 73 2013 6299 6309
192. A.L. Balboni, J.A. Hutchinson, A.J. DeCastro, P. Cherukuri, K. Liby, M.B. Sporn, G.N. Schwartz, W.A. Wells, L.F. Sempere, P.B. Yu, and J. DiRenzo ΔNp63a-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells Cancer Res. 73 2013 1020 1030
193. C. Garulli, C. Kalogris, L. Pietrella, C. Bartolacci, C. Andreani, M. Falconi, C. Marchini, and A. Amici Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling Cell. Signal. 26 2014 352 362
194. A.P. Morel, G.W. Hinkal, C. Thomas, F. Fauvet, S. Courtois-Cox, A. Wierinckx, M. Devouassoux-Shisheboran, I. Treilleux, A. Tissier, B. Gras, J. Pourchet, I. Puisieux, G.J. Browne, D.B. Spicer, J. Lachuer, S. Ansieau, and A. Puisieux EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice PLoS Genet. 8 2012 e1002723
195. S.M. Frisch, M. Schaller, and B. Cieply Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis J. Cell Sci. 126 2013 21 29
196. E. Louie, S. Nik, J.S. Chen, M. Schmidt, B. Song, C. Pacson, X.F. Chen, S. Park, J. Ju, and E.I. Chen Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation Breast Cancer Res. 12 2010 R94
197. F. Xing, H. Okuda, M. Watabe, A. Kobayashi, S.K. Pai, W. Liu, P.R. Pandey, K. Fukuda, S. Hirota, T. Sugai, G. Wakabayshi, K. Koeda, M. Kashiwaba, K. Suzuki, T. Chiba, M. Endo, Y.Y. Mo, and K. Watabe Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells Oncogene 30 2011 4075 4086
198. F.E. Lock, P.C. McDonald, Y. Lou, I. Serrano, S.C. Chafe, C. Ostlund, S. Aparicio, J.Y. Winum, C.T. Supuran, and S. Dedhar Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche Oncogene 32 2013 5210 5219
199. M. Guha, S. Srinivasan, G. Ruthel, A.K. Kashina, R.P. Carstens, A. Mendoza, C. Khanna, T. Van Winkle, and N.G. Avadhani Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells Oncogene 2013 10.1038/onc.2013.467 (Epub ahead of print)
200. S. Orecchioni, G. Gregato, I. Martin-Padura, F. Reggiani, P. Braidotti, P. Mancuso, A. Calleri, J. Quarna, P. Marighetti, C. Aldeni, G. Pruneri, S. Martella, A. Manconi, J.Y. Petit, M. Rietjens, and F. Bertolini Complementary populations of human adipose CD34 + progenitor cells promote growth, angiogenesis, and metastasis of breast cancer Cancer Res. 73 2013 5880 5891
201. I. Akalay, B. Janji, M. Hasmim, M.Z. Noman, F. Andre, P. De Cremoux, P. Bertheau, C. Badoual, P. Vielh, A.K. Larsen, M. Sabbah, T.Z. Tan, J.H. Keira, N.T. Hung, J.P. Thiery, F. Mami-Chouaib, and S. Chouaib Epithelial-to- mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis Cancer Res. 73 2013 2418 2427
202. M. Yu, A. Bardia, B.S. Wittner, S.L. Stott, M.E. Smas, D.T. Ting, S.J. Isakoff, J.C. Ciciliano, M.N. Wells, A.M. Shah, K.F. Concannon, M.C. Donaldson, L.V. Sequist, E. Brachtel, D. Sgroi, J. Baselga, S. Ramaswamy, M. Toner, D.A. Haber, and S. Maheswaran Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition Science 339 2013 580 584
203. O.H. Ocana, R. Corcoles, A. Fabra, G. Moreno-Bueno, H. Acloque, S. Vega, A. Barrallo-Gimeno, A. Cano, and M.A. Nieto Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1 Cancer Cell 22 2012 709 724
204. J.H. Tsai, J.L. Donaher, D.A. Murphy, S. Chau, and J. Yang Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis Cancer Cell 22 2012 725 736
205. R.J. Akhurst, and A. Hata Targeting the TGFβ signalling pathway in disease Nat. Rev. Drug Discov. 11 2012 790 811